ATOS Atossa Therapeutics
- 1.1200
- -0.0300-2.61%
- 1.1197
- -0.0003-0.03%
Atossa Therapeutics News
Atossa Therapeutics | 8-K: Current report
Atossa Therapeutics | 8-K: Current report
Atossa Therapeutics | 424B5: Prospectus
Atossa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.24%)
Atossa Therapeutics | 8-K: Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Atossa Therapeutics | 10-Q: Q3 2024 Earnings Report
Atossa Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.7%)
Atossa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.24%)
Atossa Therapeutics | 8-K: Current report
Atossa Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.7%)
Atossa Therapeutics | 10-Q: Q2 2024 Earnings Report
Atossa Therapeutics | 8-K: Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
Atossa Therapeutics | 8-K: Current report
Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Finn Jonathan
Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Remmel H. Lawrence
Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Steinhart Richard I
Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chen Shu-Chih
Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rees Heather
Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer QUAY STEVEN C
Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Galli Stephen J
No Data